Emcure Pharma shares hit 10% upper circuit after FY27 guidance hike; Jefferies raises target price by 8%

The Quick Take
Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brokerages turned more positive, citing robust international business, improving domestic growth and a strong product pipeline.
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to Economic Times.
Related
Business
KFC Brings the Doom: New Marvel-Inspired Menu Lands Ahead of Marvel Studios' "Avengers: Doomsday"
The venture marks KFC's largest global collaboration yet with 100 participating countries About the Collaboration: KFC is celebrating its biggest global…
Business
AudioCodes Reports Third Quarter 2026 Results
OR YEHUDA, Israel, Nov. 4, 2026 /PRNewswire/ -- Third Quarter Highlights Quarterly revenues increased by 4.2% year-over-year to $64.1 million; Quarterly…
Business
Aosom lance le Black Friday 2026 avec ses plus grosses réductions de l'année et des ventes flash à durée limitée
LONDRES, PARIS et HAMBOURG, Allemagne, 4 novembre 2026 /PRNewswire/ -- À l'approche de la période des achats de fin d'année, Aosom lancera sa promotion Black…
Business
Black Friday en Aosom: los mayores descuentos del año y ofertas flash por tiempo limitado
- Aosom da comienzo a su Black Friday 2026 con los mayores descuentos del año y ofertas flash por tiempo limitado LONDRES, PARÍS y HAMBURGO, Alemania, 4 de…
